SKK
0.036
500%
ERA
0.002
-33.3%
BMO
0.002
100%
TMX
0.002
-33.3%
PAB
0.002
100%
CZN
0.003
-25%
CCE
0.19
81%
SRL
4.02
-20.2%
VFX
0.003
50%
AQX
0.004
-20%
PUR
0.115
33.7%
FBR
0.004
-20%
CHM
0.004
33.3%
COY
0.013
-18.8%
HTG
0.026
30%
RIM
0.013
-18.8%
SMM
0.013
30%
ALM
0.005
-16.7%
TRI
0.014
27.3%
MMR
0.005
-16.7%
GTE
0.02
25%
ZMM
0.01
-16.7%
KGD
0.015
25%
TG1
0.026
-16.1%
OEL
0.005
25%
ABX
0.076
-15.6%
FXG
0.485
24.4%
BRX
0.093
-15.5%
OCN
0.11
23.6%
RML
0.051
-15%
MDX
0.064
23.1%
ANX
0.006
-14.3%
PER
0.011
22.2%
AZL
0.006
-14.3%
TZL
0.047
20.5%
LRD
0.036
-14.3%
LML
0.006
20%
WGR
0.12
-14.3%
SPX
0.006
20%
DGR
0.019
-13.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab’s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:

📱 BlinkLab’s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Watch the full interview ⚡️ https://www.youtube.com/watch?v=t7z7g9kUTvA
Register to attend Australian Equities Day: https://www.eventbrite.sg/e/spark-plus-australian-equities-day-tickets-939180011697